Otonomy to Present at Two Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber, Ph.D., president and chief executive officer, is scheduled to present at two upcoming investor conferences:

• Cowen 40th Annual Health Care Conference in Boston on March 2, 2020 at 12 p.m. ET (9 a.m. PT) 
• Oppenheimer 30th Annual Healthcare Conference in New York on March 17, 2020 at 1 p.m. ET (10 a.m. PT)

A live audio webcast of the presentations will be available through the Events page of the company's website (www.otonomy.com). 

About Otonomy Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus. For additional information please visit www.otonomy.com.

Contacts:

Media Inquiries:Spectrum ScienceChloé-Anne RamseyVice President404.865.3601 [email protected]

Investor Inquiries:Westwicke ICRRobert H. UhlManaging Director858.356.5932[email protected]

You May Also Be Interested In

• Willis Lease Finance Corporation CEO Austin C. Willis to Speak at Deutsche Bank's 16th Annual Aviation Forum
• Khaleej Times Interviews FREELANDER International CEO Lucia Mao on Global Strategy and Middle East Vision
• Sea-Doo Revamps 2027 Lineup With Higher Horsepower, Featuring Rider-Inspired Updates and Refreshed Styles for PWC and Switch